In July, the American Academy of Pediatrics released revised recommendations for the management of hypercholesterolemia in children, and within days, it had elicited a firestorm of controversy. Drs. Sarah de Ferranti and David Ludwig discuss the inclusion of statins as potential first-line pharmacologic agents.
No takes yet. Share an insight, caveat, or question.
Ferranti et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: